Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 20,000 shares at $38.49 ($768K) on 2024-04-17, disclosed to the SEC on 2024-04-17.
Scheduled sale ($768k) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.35 | 10,000 | $384K | 49.9% |
| 2 | $38.49 | 10,000 | $385K | 50.1% |
| Total | $38.42 avg | 20,000 | $768K | 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |